doi: https://doi.org/10.1136/bmj.r2028

The FDA’s February 2021 authorisation of the Q-Collar was a huge boost to company growth. A careful reading of regulatory documents, however, reveals that FDA scientists were well aware that the evidence base hadn’t demonstrated clinical effectiveness—but they approved it anyway.